VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium
Stock Information for VYNE Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.